Peter Grimison

5.1k total citations
135 papers, 2.2k citations indexed

About

Peter Grimison is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Peter Grimison has authored 135 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Oncology, 49 papers in Pulmonary and Respiratory Medicine and 45 papers in Surgery. Recurrent topics in Peter Grimison's work include Testicular diseases and treatments (27 papers), Sarcoma Diagnosis and Treatment (26 papers) and Cancer Treatment and Pharmacology (19 papers). Peter Grimison is often cited by papers focused on Testicular diseases and treatments (27 papers), Sarcoma Diagnosis and Treatment (26 papers) and Cancer Treatment and Pharmacology (19 papers). Peter Grimison collaborates with scholars based in Australia, United States and New Zealand. Peter Grimison's co-authors include Martin R. Stockler, Phyllis Butow, David Goldstein, Susanna B. Park, Nicole Rankin, Joanne Shaw, Melanie A. Price, Guy C. Toner, Madeleine King and Ian Olver and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Peter Grimison

125 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Grimison Australia	28	1.2k	441	405	325	270	135	2.2k
Anne Blaes United States	29	1.7k 1.4×	506 1.1×	454 1.1×	469 1.4×	293 1.1×	194	3.6k
Shari Goldfarb United States	26	1.3k 1.1×	289 0.7×	387 1.0×	473 1.5×	256 0.9×	96	3.1k
Deborah Fenlon United Kingdom	26	1.2k 1.0×	220 0.5×	392 1.0×	395 1.2×	403 1.5×	89	2.4k
David Wyld Australia	24	1.2k 0.9×	201 0.5×	423 1.0×	342 1.1×	261 1.0×	127	2.1k
G.M. Kiebert Netherlands	24	770 0.6×	445 1.0×	440 1.1×	289 0.9×	197 0.7×	35	2.3k
Karen Ruth United States	33	1.2k 1.0×	711 1.6×	855 2.1×	442 1.4×	130 0.5×	129	3.3k
Rachel Waters United Kingdom	19	1.1k 0.9×	882 2.0×	348 0.9×	391 1.2×	330 1.2×	30	2.7k
Laura Giordano Italy	31	982 0.8×	305 0.7×	873 2.2×	215 0.7×	246 0.9×	165	3.3k
Ingrid Glimelius Sweden	30	1.7k 1.4×	455 1.0×	638 1.6×	484 1.5×	612 2.3×	181	3.6k
H Ziegler Germany	27	1.5k 1.3×	725 1.6×	558 1.4×	351 1.1×	285 1.1×	60	2.9k

Countries citing papers authored by Peter Grimison

Since Specialization

Citations

This map shows the geographic impact of Peter Grimison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Grimison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Grimison more than expected).

Fields of papers citing papers by Peter Grimison

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Grimison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Grimison. The network helps show where Peter Grimison may publish in the future.

Co-authorship network of co-authors of Peter Grimison

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Grimison. A scholar is included among the top collaborators of Peter Grimison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Grimison. Peter Grimison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Grimison, Peter, et al.. (2026). A Case Report of Promising Response to Combination Therapy With an Immune Checkpoint Inhibitor (Pembrolizumab) and Multi‐Targeted Tyrosine Kinase Inhibitor (Pazopanib) in Metastatic De‐Differentiated Chondrosarcoma. Cancer Reports. 9(2). e70426–e70426.

Srinivasa, Sreesha P., Betty Zhang, Annabel Goodwin, et al.. (2025). EP300::VGLL3 rhabdomyosarcoma: a potential distinct indolent adult rhabdomyosarcoma subtype. 2. 100012–100012. 1 indexed citations

Yeo, Dannel, Andrew Leach, Kevin J. Spring, et al.. (2025). Portal venous circulating tumor cells as a biomarker for relapse prediction in resected pancreatic cancer. Cellular and Molecular Life Sciences. 82(1). 155–155. 2 indexed citations

Shepherd, Heather L., et al.. (2024). Changes in psychosocial distress and the number and types of problems reported by patients with cancer when routine screening is integrated within cancer services. 6(2).

Qiu, Min, et al.. (2024). Metastatic Non‐Myofibroblastic Sarcoma Harbouring EML4‐ALK Fusion—Dramatic Response to ALK Tyrosine Kinase Inhibitors and Development of Resistance Mutations. Cancer Reports. 7(8). e2164–e2164. 1 indexed citations

Li, Tiffany, Hannah C. Timmins, Lisa G. Horvath, et al.. (2024). Impact of Pain on Symptom Burden in Chemotherapy-Induced Peripheral Neurotoxicity. Journal of the National Comprehensive Cancer Network. 22(2). 108–116. 6 indexed citations

Park, Susanna B., et al.. (2024). Electroacupuncture use for treatment of taxane-induced peripheral neuropathy in patients with breast cancer: protocol for a pilot, randomised, blinded, sham-controlled trial (EA for CIPN). BMJ Open. 14(1). e076391–e076391. 2 indexed citations

Connolly, Elizabeth A., Peter Grimison, Lisa G. Horvath, Phillip J. Robinson, & Roger R. Reddel. (2023). Quantitative proteomic studies addressing unmet clinical needs in sarcoma. Frontiers in Oncology. 13. 1126736–1126736. 6 indexed citations

Connolly, Elizabeth A., et al.. (2023). A systematic review of the role of chemotherapy in retroperitoneal sarcoma by the Australia and New Zealand sarcoma association clinical practice guidelines working party. Cancer Treatment Reviews. 122. 102663–102663. 4 indexed citations

10.

Lewin, Jeremy, Andrew Weickhardt, James Lynam, et al.. (2023). Patterns of Relapse in Australian Patients With Clinical Stage 1 Testicular Cancer: Utility of the Australian and New Zealand Urogenital and Prostate Cancer Trials Group Surveillance Recommendations. JCO Oncology Practice. 19(11). 973–980. 3 indexed citations

11.

Lewin, Jeremy, Elizabeth Liow, Haryana M. Dhillon, et al.. (2023). Trial in progress: PRESTIGE—Primary retroperitoneal lymph node dissection (RPLND) for clinical stage II (CSII) testicular germ cell tumour (TGCT) and its impact on health-related quality of life (HRQoL) compared to chemotherapy or radiotherapy.. Journal of Clinical Oncology. 41(6_suppl). TPS433–TPS433. 1 indexed citations

12.

Mizrahi, David, David Goldstein, Matthew C. Kiernan, et al.. (2022). Development and consensus process for a clinical pathway for the assessment and management of chemotherapy-induced peripheral neuropathy. Supportive Care in Cancer. 30(7). 5965–5974. 8 indexed citations

13.

Grimison, Peter, Christine Chevreau, Silvia Stacchiotti, et al.. (2022). Long-term follow-up of nilotinib in patients with advanced tenosynovial giant cell tumours. European Journal of Cancer. 173. 219–228. 17 indexed citations

14.

Yeo, Dannel, et al.. (2022). Exploring the Clinical Utility of Pancreatic Cancer Circulating Tumor Cells. International Journal of Molecular Sciences. 23(3). 1671–1671. 35 indexed citations

15.

Butow, Phyllis, Ilse Mesters, Terry Boyle, et al.. (2021). Psychosocial well-being and supportive care needs of cancer patients and survivors living in rural or regional areas: a systematic review from 2010 to 2021. Supportive Care in Cancer. 30(2). 1021–1064. 51 indexed citations

16.

Smith, Allan Ben, Claudia Rutherford, Phyllis Butow, et al.. (2017). A systematic review of quantitative observational studies investigating psychological distress in testicular cancer survivors. Psycho-Oncology. 27(4). 1129–1137. 52 indexed citations

17.

Smith, Allan Ben, Ian Olver, Peter Grimison, et al.. (2017). e-TC: Development and pilot testing of a web-based intervention to reduce anxiety and depression in survivors of testicular cancer. European Journal of Cancer Care. 26(6). e12698–e12698. 28 indexed citations

18.

Butow, PN, et al.. (2014). Evaluating an evidence-based care pathway for the management of anxiety and depression in cancer care. The Sydney eScholarship Repository (The University of Sydney). 1 indexed citations

19.

Costa, Daniel, Madeleine King, Neil K. Aaronson, et al.. (2014). The Development of Cancer-Specific Multi-Attribute Utility Instruments From the Eortc Qlq-C30 and Fact-G. Asia-Pacific Journal of Clinical Oncology. 10. 31–31. 1 indexed citations

20.

Grimison, Peter, Martin R. Stockler, Damien Thomson, et al.. (2010). Comparison of Two Standard Chemotherapy Regimens for Good-Prognosis Germ Cell Tumors: Updated Analysis of a Randomized Trial. JNCI Journal of the National Cancer Institute. 102(16). 1253–1262. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact